Host Biomarkers Reflect Prognosis in Patients Presenting With Moderate Coronavirus Disease 2019: A Prospective Cohort Study

  • for the PRIORITISE Study Investigators

Research output: Contribution to journalArticlepeer-review

Abstract

Efficient resource allocation is essential for effective pandemic response. We measured host biomarkers in 420 patients presenting with moderate coronavirus disease 2019 and found that different biomarkers predict distinct clinical outcomes. Interleukin (IL)-1ra, IL-6, IL-10, and IL-8 exhibit dose-response relationships with subsequent disease progression and could potentially be useful for multiple use-cases.

Original languageEnglish
Article numberofac526
JournalOpen Forum Infectious Diseases
Volume9
Issue number10
DOIs
Publication statusPublished - 1 Oct 2022
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • COVID-19
  • host biomarker
  • prognosis

Fingerprint

Dive into the research topics of 'Host Biomarkers Reflect Prognosis in Patients Presenting With Moderate Coronavirus Disease 2019: A Prospective Cohort Study'. Together they form a unique fingerprint.

Cite this